ExpreS2ion Biotech Holding AB (publ)
ExpreS2ion Biotech Holding AB (publ), a biotechnology company, develops vaccines and biologics products to address critical unmet medical needs in the Nordics and internationally. The company's lead asset is ES2B-C001, a therapeutic vaccine which is in Phase 1 clinical trials for breast cancer that targets the human epidermal growth factor receptor 2. It is also developing ES2B-I002, a cytomegalo… Read more
Market Cap & Net Worth: ExpreS2ion Biotech Holding AB (publ) (5JD0)
ExpreS2ion Biotech Holding AB (publ) (F:5JD0) has a market capitalization of $1.36 Million (€1.32 Million) as of March 19, 2026. Listed on the F stock exchange, this Germany-based company holds position #36026 globally and #4355 in its home market, demonstrating a -1.83% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying ExpreS2ion Biotech Holding AB (publ)'s stock price €0.37 by its total outstanding shares 3530233 (3.53 Million).
ExpreS2ion Biotech Holding AB (publ) Market Cap History: 2026 to 2026
ExpreS2ion Biotech Holding AB (publ)'s market capitalization history from 2026 to 2026. Data shows growth from $1.36 Million to $1.36 Million (0.00% CAGR).
ExpreS2ion Biotech Holding AB (publ) Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how ExpreS2ion Biotech Holding AB (publ)'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 5JD0 by Market Capitalization
Companies near ExpreS2ion Biotech Holding AB (publ) in the global market cap rankings as of March 19, 2026.
Key companies related to ExpreS2ion Biotech Holding AB (publ) by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #165 globally with a market cap of $114.33 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #285 globally with a market cap of $73.32 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #340 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #497 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #165 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $114.33 Billion | $451.59 |
| #285 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $73.32 Billion | $744.12 |
| #340 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #497 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
ExpreS2ion Biotech Holding AB (publ) Historical Marketcap From 2026 to 2026
Between 2026 and today, ExpreS2ion Biotech Holding AB (publ)'s market cap moved from $1.36 Million to $ 1.36 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €1.36 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of ExpreS2ion Biotech Holding AB (publ) was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.36 Million USD |
| MoneyControl | $1.36 Million USD |
| MarketWatch | $1.36 Million USD |
| marketcap.company | $1.36 Million USD |
| Reuters | $1.36 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.